Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case–Control Study
International Journal of Molecular Sciences · 25.06.2026 · 27 (13) · 5747
DOI: 10.3390/ijms27135747 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2026. Verfasst von Maciej Skrzypek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland. Hauptthemen laut MEDLINE: Arylamine N-Acetyltransferase, Endometrial Neoplasms, Cytochrome P-450 CYP1A1, Cytochrome P-450 CYP2D6. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Abstract (Originalsprache)
Cancer risk may be influenced by genetic variation and altered expression of xenobiotic-metabolizing enzymes, yet their role in endometrial cancer remains incompletely understood. This study evaluated the association between four polymorphisms in xenobiotic metabolism-related genes CYP1A1 rs1799814, CYP2D6 rs3892097, NAT1 rs72554606, and NAT2 rs1799930 and the risk of endometrial cancer, and assessed CYP1A1 and CYP2D6 expression in tumor and control tissues. Genetic association analyses, including multivariate and histology-stratified models, were performed, and gene expression levels were compared between cancer and control tissues. Variants in NAT2, CYP1A1, and CYP2D6 were significantly associated with an increased risk of endometrial cancer, whereas NAT1 rs72554606 showed a protective effect, particularly in the dominant model. The strongest association was observed for NAT2 rs1799930 in additive and recessive models. Expression analysis revealed significantly higher CYP1A1 and CYP2D6 levels in tumor tissues than in control tissues. Stratified analyses showed generally consistent effects, especially for endometrioid carcinoma, although estimates for the serous subtype were limited by sample size. These findings suggest that polymorphisms and altered expression of xenobiotic-metabolizing genes may contribute to endometrial carcinogenesis. Further studies, including independent validation and analyses of gene–environment interactions, are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 92-215 Lodz, Poland.
- Clinical Department of Gynecologic Oncology, Faculty of Health Sciences, Medical University of Lodz, 92-213 Lodz, Poland.
ORCID-Profile: Monika Gogolewska, Jacek Kabziński
Förderung
- Medical University of Lodz
Zitieren
APA
Skrzypek, M., Gogolewska, M., Bieńkiewicz, A., Wójcik-Krowiranda, K., Majsterek, I., & Kabziński, J. (2026). Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case–Control Study. International Journal of Molecular Sciences, 27(13), 5747. https://doi.org/10.3390/ijms27135747
Vancouver
Skrzypek M, Gogolewska M, Bieńkiewicz A, Wójcik-Krowiranda K, Majsterek I, Kabziński J. Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case–Control Study. International Journal of Molecular Sciences. 2026;27(13):5747. doi:10.3390/ijms27135747
BibTeX
@article{Skrzypek2026,
author = {Skrzypek, Maciej and Gogolewska, Monika and Bieńkiewicz, Andrzej and Wójcik-Krowiranda, Katarzyna and Majsterek, Ireneusz and Kabziński, Jacek},
title = {Association of Selected Genetic Variants in CYP1A1, CYP2D6, NAT1 and NAT2 with Endometrial Cancer Risk: A Preliminary Case–Control Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5747},
doi = {10.3390/ijms27135747}
}
EUVIMED